Open, Single Center, Three Periods, Fixed Sequence Design Study on the Effects of Clopidogrel Co-administration on the Pharmacokinetics of Neramexane

NCT00936026 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: Neramexane

Sponsor

Merz Pharmaceuticals GmbH